An overview of human leptospirosis vaccine design and future perspectives
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Carolina R. Felix Bianca S. Siedler Liana N. Barbosa Gabriana R. Timm Johnjoe McFadden Alan J. A. McBride Source Type: research

Assays used to assess biosimilarity of therapies for inflammatory bowel disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Ido Veisman Shomron Ben-Horin Source Type: research

Current discovery strategies for hepatocellular carcinoma therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Qiuzi Dai Cunlong Zhang Zigao Yuan Qinsheng Sun Yuyang Jiang Source Type: research

Toward the identification of ZDHHC enzymes required for palmitoylation of viral protein as potential drug targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Mohamed Rasheed Gadalla Michael Veit Source Type: research

Is anti-ageing drug discovery becoming a reality?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Alexey Moskalev Source Type: research

Drug design strategies with metal-hydroxyquinoline complexes
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Ivana M. Savi ć-Gajić Ivan M. Savi ć Source Type: research

What is the current value of fluorescence polarization assays in small molecule screening?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Asko Uri Olivier Etebe Nonga Source Type: research

Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Alan Talevi Carolina L. Bellera Source Type: research

In vitro models of neuromuscular junctions and their potential for novel drug discovery and development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Olaia F Vila Yihuai Qu Gordana Vunjak-Novakovic Source Type: research

Thermodynamic profiling for fragment-based lead discovery and optimization
Volume 15, Issue 1, January 2020, Page 117-129 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Gy örgy G. Ferenczy Gy örgy M. Keserű Source Type: research

Design and optimization strategies for the development of new drugs that treat chronic kidney disease
Volume 15, Issue 1, January 2020, Page 101-115 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Adri án M. Ramos Beatriz Fern ández-Fernández Mar ía Vanessa Pérez-Gómez Sol Mar ía Carriazo Julio Mar ía Dolores Sanchez-Niño Ana Sanz Marta Ruiz-Ortega Alberto Ortiz Source Type: research

Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
Volume 15, Issue 1, January 2020, Page 63-83 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Kenneth K.W. To Winnie Fong Christy W.S. Tong Mingxia Wu Wei Yan William C.S. Cho Source Type: research

Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson ’s disease therapeutics
Volume 15, Issue 1, January 2020, Page 53-62 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 22, 2019 Category: Drugs & Pharmacology Authors: Kalliopi Moschovou Georgia Melagraki Thomas Mavromoustakos Lefteris C. Zacharia Antreas Afantitis Source Type: research

Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 19, 2019 Category: Drugs & Pharmacology Authors: Alan Talevi Carolina L. Bellera Source Type: research

In vitro models of neuromuscular junctions and their potential for novel drug discovery and development
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 19, 2019 Category: Drugs & Pharmacology Authors: Olaia F Vila Yihuai Qu Gordana Vunjak-Novakovic Source Type: research

What is the current value of fluorescence polarization assays in small molecule screening?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 13, 2019 Category: Drugs & Pharmacology Authors: Asko Uri Olivier Etebe Nonga Source Type: research

Drug design strategies with metal-hydroxyquinoline complexes
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 12, 2019 Category: Drugs & Pharmacology Authors: Ivana M. Savi ć-Gajić Ivan M. Savi ć Source Type: research

Is anti-ageing drug discovery becoming a reality?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 11, 2019 Category: Drugs & Pharmacology Authors: Alexey Moskalev Source Type: research

Current discovery strategies for hepatocellular carcinoma therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 7, 2019 Category: Drugs & Pharmacology Authors: Qiuzi Dai Cunlong Zhang Zigao Yuan Qinsheng Sun Yuyang Jiang Source Type: research

Toward the identification of ZDHHC enzymes required for palmitoylation of viral protein as potential drug targets
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 7, 2019 Category: Drugs & Pharmacology Authors: Mohamed Rasheed Gadalla Michael Veit Source Type: research

Assays used to assess biosimilarity of therapies for inflammatory bowel disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - December 6, 2019 Category: Drugs & Pharmacology Authors: Ido Veisman Shomron Ben-Horin Source Type: research

Drug screening of rhodanine derivatives for antibacterial activity
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 28, 2019 Category: Drugs & Pharmacology Authors: Suresh Maddila Sridevi Gorle Sreekantha B Jonnalagadda Source Type: research

An overview of human leptospirosis vaccine design and future perspectives
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 28, 2019 Category: Drugs & Pharmacology Authors: Carolina R. Felix Bianca S. Siedler Liana N. Barbosa Gabriana R. Timm Johnjoe McFadden Alan J. A. McBride Source Type: research

Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 27, 2019 Category: Drugs & Pharmacology Authors: Kuldeep K. Roy Mushtaq Ahmad Wani Source Type: research

Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson ’s disease therapeutics
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 20, 2019 Category: Drugs & Pharmacology Authors: Kalliopi Moschovou Georgia Melagraki Thomas Mavromoustakos Lefteris C. Zacharia Antreas Afantitis Source Type: research

Thermodynamic profiling for fragment-based lead discovery and optimization
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 19, 2019 Category: Drugs & Pharmacology Authors: Gy örgy G. Ferenczy Gy örgy M. Keserű Source Type: research

Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 19, 2019 Category: Drugs & Pharmacology Authors: Kenneth K.W. To Winnie Fong Christy W.S. Tong Mingxia Wu Wei Yan William C.S. Cho Source Type: research

Is there enough focus on lipophilicity in drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 18, 2019 Category: Drugs & Pharmacology Authors: Sonia Lobo Source Type: research

Design and optimization strategies for the development of new drugs that treat chronic kidney disease
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 18, 2019 Category: Drugs & Pharmacology Authors: Adri án M. Ramos Beatriz Fern ández-Fernández Mar ía Vanessa Pérez-Gómez Sol Mar ía Carriazo Julio Mar ía Dolores Sanchez-Niño Ana Sanz Marta Ruiz-Ortega Alberto Ortiz Source Type: research

Using Xenopus oocytes in neurological disease drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - November 1, 2019 Category: Drugs & Pharmacology Authors: Steven L. Zeng Leland C. Sudlow Mikhail Y. Berezin Source Type: research

Why hasn ’t there been more progress in new Chagas disease drug discovery?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 31, 2019 Category: Drugs & Pharmacology Authors: Alane Beatriz Vermelho Giseli Capaci Rodrigues Claudiu T. Supuran Source Type: research

Considerations for future tau-targeted therapeutics: can they deliver?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Wendy Noble Maria Jimenez-Sanchez Beatriz G. Perez-Nievas Diane P. Hanger Source Type: research

The preclinical discovery and development of paliperidone for the treatment of schizophrenia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Anna Weso łowska Magdalena Jastrz ębska-Więsek Agnieszka Cios Anna Partyka Source Type: research

The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Filip Machaj Jakub Rosik Bartosz Szostak Andrzej Pawlik Source Type: research

Considerations for future tau-targeted therapeutics: can they deliver?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Wendy Noble Maria Jimenez-Sanchez Beatriz G. Perez-Nievas Diane P. Hanger Source Type: research

The preclinical discovery and development of paliperidone for the treatment of schizophrenia
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Anna Weso łowska Magdalena Jastrz ębska-Więsek Agnieszka Cios Anna Partyka Source Type: research

The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 30, 2019 Category: Drugs & Pharmacology Authors: Filip Machaj Jakub Rosik Bartosz Szostak Andrzej Pawlik Source Type: research

Recent advances from metabolomics and lipidomics application in alzheimer ’s disease inspiring drug discovery
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 17, 2019 Category: Drugs & Pharmacology Authors: Miroslava Cuperlovic-Culf Amanpreet Badhwar Source Type: research

Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 14, 2019 Category: Drugs & Pharmacology Authors: Rosa Maria Paragliola Andrea Corsello Valeria Del Gatto Giampaolo Papi Alfredo Pontecorvi Salvatore Maria Corsello Source Type: research

How does a researcher choose the best rodent model for their Alzheimer ’s disease drug discovery study?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 8, 2019 Category: Drugs & Pharmacology Authors: Debby Van Dam Peter Paul De Deyn Source Type: research

Streamlining drug discovery assays for cardiovascular disease using zebrafish
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - October 1, 2019 Category: Drugs & Pharmacology Authors: Alexander Pott Wolfgang Rottbauer Steffen Just Source Type: research

What are the challenges in commercial non-tuberculous mycobacteria (NTM) drug discovery and how should we move forward?
. (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 30, 2019 Category: Drugs & Pharmacology Authors: Graham S Timmins Source Type: research

Redirecting the revolution: new developments in drug development for psychiatry
Volume 14, Issue 12, December 2019, Page 1213-1219 . (Source: Expert Opinion on Drug Discovery)
Source: Expert Opinion on Drug Discovery - September 23, 2019 Category: Drugs & Pharmacology Authors: Linda S. Brady William Z. Potter Joshua A. Gordon Source Type: research